文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Bikramajit Singh Saroya
发表
Off-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancer
Wafik S El-Deiry, W. El-Deiry, Zhaohai Yang, 2013, Cancer biology & therapy.